TIFFANY AUTRY: Open Payments
NPI 1003389875 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 47 payments from 7 companies in 2025. Trend: 2023 $850 · 2024 $1,073 · 2025 $1,319
Food & beverage: $1,219Education: $100
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 7 | $525 |
| Janssen Biotech, Inc. | 16 | $384 |
| Galderma Laboratories, L.P. | 11 | $167 |
| Lilly USA, LLC | 9 | $148 |
| Organon LLC | 2 | $44 |
| ABBVIE INC. | 1 | $34 |
| UCB, Inc. | 1 | $17 |
Products named: DAXXIFY, TREMFYA, NEMLUVIO, TALTZ, DAXI, SKYRIZI, EBGLYSS, Bimzelx.
Industry payments across NM — which companies pay providers there.
